unknown
Stage
1
Investors
About
A-Alpha Bio is a biotechnology company that uses synthetic biology and machine learning to measure, predict, and engineer protein–protein interactions. Its AlphaSeq platform employs genetically engineered cells to experimentally measure millions of protein–protein interaction affinities at library-on-library scale to support therapeutic discovery.
Explore A-Alpha Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.